MindImmune Therapeutics closes $500K seed round led by Slater Fund

MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
MINDIMMUNE THERAPEUTICS is a South Kingstown-based pharmaceutical startup. Commerce RI awarded the company a $50,000 Innovation Voucher grant to partner with the University of Rhode Island and establish animal models of brain immune system dysfunction, as a means to screen for new Alzheimer’s disease therapies. Above, the MindImmune Therapeutics lab at the University of Rhode Island. /COURTESY MINDIMMUNE THERAPEUTICS
PROVIDENCE – MindImmune Therapeutics Inc., a pharmaceutical startup, closed its second seed round of $500,000 on Monday. The round was led by a $250,000 investment from Slater Technology Fund, a publicly funded venture capital firm in Providence. MindImmune, based out of the University of Rhode Island, is developing drugs to target the immune system as…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -